These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21111946)

  • 21. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.
    Jerez A; Ortuño FJ; Osma Mdel M; Español I; González AD; Roldán V; de Arriba F; Vicente V
    Ann Med; 2009; 41(7):547-58. PubMed ID: 19634064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
    Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
    Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
    Kristinsson SY; Björkholm M; Schulman S; Landgren O
    Semin Hematol; 2011 Jan; 48(1):46-54. PubMed ID: 21232658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
    Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
    Schmitz MF; Otten HG; Franssen LE; van Dorp S; Strooisma T; Lokhorst HM; van de Donk NW
    Haematologica; 2014 Dec; 99(12):1846-53. PubMed ID: 25193963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
    Sverrisdóttir IS; Lund SH; Turesson I; Björkholm M; Goldin LR; Landgren O; Kristinsson SY
    Br J Haematol; 2019 Jul; 186(1):37-44. PubMed ID: 30906990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults.
    Guerard EJ; Tuchman SA
    Clin Geriatr Med; 2016 Feb; 32(1):191-205. PubMed ID: 26614868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2006 Sep; 134(6):573-89. PubMed ID: 16938117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monoclonal gammopathies of undetermined significance called "MGUS"].
    Clément F
    Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism in patients with monoclonal gammopathy of undetermined significance.
    Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Jaiyesimi I; Daw HA
    Clin Adv Hematol Oncol; 2009 Dec; 7(12):827-32. PubMed ID: 20332755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L; Goldaniga M; Guffanti A; Broglia C; Cortelazzo S; Rossi A; Morra E; Colombi M; Callea V; Pogliani E; Ilariucci F; Luminari S; Morel P; Merlini G; Gobbi P
    J Clin Oncol; 2005 Jul; 23(21):4662-8. PubMed ID: 16034042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.
    Soltero L; Carbajal H; Xu J; McCarthy J; Suki WN; Gaber AO; Adrogué HE
    Clin Transplant; 2012; 26(2):300-4. PubMed ID: 22044717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of a population based cohort with monoclonal proteinaemia.
    Schaar CG; le Cessie S; Snijder S; Franck PF; Wijermans PW; Ong C; Kluin-Nelemans H
    Br J Haematol; 2009 Jan; 144(2):176-84. PubMed ID: 19036113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
    Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
    Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma.
    Neriishi K; Nakashima E; Suzuki G
    Br J Haematol; 2003 May; 121(3):405-10. PubMed ID: 12716362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of monoclonal gammopathies of undetermined significance.
    Vogt RF; Marti GE
    Br J Haematol; 2007 Dec; 139(5):687-9. PubMed ID: 18021082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
    Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
    J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
    Madan S; Greipp PR
    Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.